Loading…
Reported covered position: Aide to Rep. Joe Heck (R-NV)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WOMENHEART via CURA STRATEGIES
2024 · first_quarter · 1T
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2024 · first_quarter · 1T
Source: Senate LDA
Heart Health Enhancement through Access to Research and Training Act
Client: WOMENHEART · Firm: CURA STRATEGIES
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Heart Health Enhancement through Access to Research and Training Act
Client: WOMENHEART · Firm: CURA STRATEGIES
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Quality Care for Nursing Home Residents and Workers During COVID–19 and Beyond Act
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Getting Americans Safely Back to Work Act of 2021
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Quality Care for Nursing Home Residents and Workers During COVID–19 Act
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Quality Care for Nursing Home Residents and Workers During COVID–19 and Beyond Act
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Quality Care for Nursing Home Residents and Workers During COVID–19 and Beyond Act
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Getting Americans Safely Back to Work Act of 2021
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Getting Americans Safely Back to Work Act of 2021
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Quality Care for Nursing Home Residents and Workers During COVID–19 Act
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Quality Care for Nursing Home Residents and Workers During COVID–19 Act
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Passage of the Access to AEDs Act, potential Peer Support research legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOMENHEART via CURA STRATEGIES
2023 · fourth_quarter · 4A
Passage of the Heart Health Enhancement through Access to Research and Training Act (H.R. 880), the Treat and Reduce Obesity Act of 2023 (H.R. 4818/S. 2407), and the SAFE STEP Act (H.R. 2630/S. 652)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOMENHEART via CURA STRATEGIES
2023 · fourth_quarter · RR
Policies supporting female cardiovascular disease patients, research around cardiovascular disease
THE MENDED HEARTS, INC. via CURA STRATEGIES
2023 · fourth_quarter · Q4
Passage of the Access to AEDs Act, potential Peer Support research legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2023 · fourth_quarter · Q4
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2023 · fourth_quarter · Q4
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Q4
Medicare/Insurance coverage for innovative diagnostic testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2023 · third_quarter · Q3
Passage of the Access to AEDs Act, potential Peer Support research legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2023 · third_quarter · Q3
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
PKD FOUNDATION via CURA STRATEGIES
2023 · third_quarter · Q3
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Q3
Medicare/Insurance coverage for innovative diagnostic testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2023 · second_quarter · Q2
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
LAS VEGAS METROPOLITAN POLICE DEPARTMENT FOUNDATION via CURA STRATEGIES
2023 · first_quarter · 1T
Grant funding for law enforcement training facilities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2023 · first_quarter · Q1
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
LAS VEGAS METROPOLITAN POLICE DEPARTMENT FOUNDATION via CURA STRATEGIES
2022 · fourth_quarter · Q4
Federal appropriations to support law enforcement training facilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2022 · fourth_quarter · Q4
Infection prevention and nasal decolonization as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2022 · third_quarter · Q3
Infection prevention and nasal decolonization as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
LAS VEGAS METROPOLITAN POLICE DEPARTMENT FOUNDATION via CURA STRATEGIES
2022 · third_quarter · Q3
Federal appropriations to support law enforcement training facilities
Filing targets: SENATE
LAS VEGAS METROPOLITAN POLICE DEPARTMENT FOUNDATION via CURA STRATEGIES
2022 · second_quarter · Q2
Federal appropriations to support law enforcement training facilities
Filing targets: SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2022 · second_quarter · Q2
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
LAS VEGAS METROPOLITAN POLICE DEPARTMENT FOUNDATION via CURA STRATEGIES
2022 · first_quarter · Q1
Federal appropriations to support law enforcement training facilities
Filing targets: SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2022 · first_quarter · Q1
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2021 · fourth_quarter · Q4
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2021 · third_quarter · Q3
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
LAS VEGAS METROPOLITAN POLICE DEPARTMENT FOUNDATION via CURA STRATEGIES
2021 · third_quarter · Q3
DOJ COPS Technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Q3
Outreach to Congress and the Biden admin on post-Immuno Bill activities like surprise medical billing and insurance coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2021 · second_quarter · Q2
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Q2
Outreach to Congress and the Biden admin on post-Immuno Bill activities like surprise medical billing and insurance coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LAS VEGAS METROPOLITAN POLICE DEPARTMENT FOUNDATION via CURA STRATEGIES
2021 · second_quarter · Q2
DOJ COPS Technology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LAS VEGAS METROPOLITAN POLICE DEPARTMENT FOUNDATION via CURA STRATEGIES
2021 · second_quarter · RR
Department of Justice; Community Oriented Policing Services (COPS); COPS Law Enforcement Technology
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2021 · first_quarter · RA
Infection prevention strategies
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2020 · third_quarter · RA
Infection prevention strategies
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE